Shares in Biogen have come under pressure after chief executive Michel Vounatsos admitted that the company is facing a much slower than anticipated rollout of its controversial Alzheimer's disease ...

If lecanemab is approved it could be after the departure of Biogen chief executive Michel Vounatsos, who is leaving the company in the wake of a tumultuous few months following the approval of ...

Jake Wallis Simons and his family ditched the Alps for cheaper destination Zakopane. Here, he reveals why he would recommend it, even though there was not a speck of white in sight. He writes ...

Veteran defenceman blasting his teammates near end of ragged first period might have been turning point in win over Utah.